| | | | | | | |
 | CSL LIMITED | -0.48% | 1.12% | 2.41% | 18.15% | -5.74% | 101 251 |
 | SAMSUNG BIOLOGICS CO.,LTD. | -0.38% | 0.25% | -3.17% | 5.02% | 64.60% | 45 824 |
 | BIOGEN INC. | -0.14% | 4.21% | 5.42% | 32.93% | 4.95% | 42 037 |
 | WUXI BIOLOGICS (CAYMAN) INC. | -0.63% | 1.42% | 18.55% | -8.10% | 107.46% | 38 535 |
 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | -0.85% | -1.82% | 19.07% | -3.11% | 75.50% | 24 669 |
| BIOMARIN PHARMACEUTICAL INC. | 0.82% | 7.12% | 13.04% | 39.76% | 35.79% | 21 741 |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. | -2.22% | -3.88% | 7.18% | -15.61% | --.--% | 18 141 |
| WALVAX BIOTECHNOLOGY CO., LTD. | -0.44% | -0.02% | 1.54% | -16.44% | 44.61% | 9 622 |
| BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | -2.77% | -4.08% | -4.63% | 4.85% | 51.78% | 9 150 |
| INNOVENT BIOLOGICS, INC. | 1.73% | 8.71% | 40.30% | 40.51% | 49.92% | 9 055 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | 0.97% | -1.55% | -14.23% | -9.57% | 65.74% | 8 313 |
 | GRIFOLS, S.A. | 0.92% | 4.15% | 17.69% | -19.37% | -59.11% | 8 103 |
| CELLTRION HEALTHCARE CO., LTD. | 0.85% | 2.43% | 1.72% | -3.22% | 15.65% | 7 708 |
 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | 0.17% | 0.70% | 6.82% | 28.32% | 30.69% | 6 611 |
| SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. | -0.16% | 0.16% | 0.79% | -5.61% | -20.22% | 6 350 |
| | | | | | | |
| | Moyenne | -0.17% | 1.26% | 7.50% | 5.90% | 32.97% | |
| | Moyenne pondérée par Capi. | -0.37% | 1.35% | 6.58% | 10.61% | 32.41% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
